P.05.13: Clinical Effectiveness of Group-Based Cognitive-Behavioural Therapy On Anxiety, Depression, Quality of Life in Inflammatory Bowel Disease

2017 ◽  
Vol 49 ◽  
pp. e161-e162
Author(s):  
E. Geccherle ◽  
A. Variola ◽  
M. Fortuna ◽  
G. Deledda ◽  
A. Geccherle
Keyword(s):  
Quality Of Life ◽  
Inflammatory Bowel Disease ◽  
Cognitive Behavioural Therapy ◽  
Bowel Disease ◽  
Clinical Effectiveness ◽  
Behavioural Therapy ◽  
Cognitive Behavioural ◽  
Inflammatory Bowel ◽  
Anxiety Depression

scholarly journals Correlation between anxiety/depression and quality of life in patients with inflammatory bowel disease

2015 ◽  
Vol 23 (24) ◽  
pp. 3945
Author(s):  
Ling-Hua Chen ◽  
Xue-Zhu Huang ◽  
Hui Zhao ◽  
Ying Lin ◽  
Feng Li ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Inflammatory Bowel Disease ◽  
Bowel Disease ◽  
Inflammatory Bowel ◽  
Anxiety Depression

The Impact of Disease Specific Knowledge on Anxiety, Depression, and Quality of Life in Patients With Inflammatory Bowel Disease

2018 ◽  
Vol 113 (Supplement) ◽  
pp. S362-S363
Author(s):  
Aya Hamadeh ◽  
Mohamad Chahrour ◽  
Habib El-Khoury ◽  
Jad M. Kfouri ◽  
Mohammad N. Hosni ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Inflammatory Bowel Disease ◽  
Bowel Disease ◽  
Specific Knowledge ◽  
Inflammatory Bowel ◽  
Anxiety Depression ◽  
The Impact ◽  
Disease Specific

scholarly journals Factors Associated with Poor Quality of Life in a Canadian Cohort of Patients with Inflammatory Bowel Disease: A Cross-sectional Study

2020 ◽  
Author(s):  
Amir Nazarian ◽  
Kirles Bishay ◽  
Reza Gholami ◽  
Michael A Scaffidi ◽  
Rishad Khan ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Inflammatory Bowel Disease ◽  
Bowel Disease ◽  
Clinical Remission ◽  
Care Center ◽  
Tertiary Care ◽  
Factors Associated ◽  
Inflammatory Bowel ◽  
Anxiety Depression

Abstract Background Health-related quality of life (QoL) is often adversely affected in patients with inflammatory bowel disease (IBD). We aimed to identify factors associated with poor QoL among Canadian patients with IBD in clinical remission. Methods We enrolled patients at a single academic tertiary care center with inactive IBD. All eligible patients completed a series of questionnaires that included questions on demographics, disease activity, anxiety, depression and the presence of irritable bowel syndrome (IBS) symptoms. Stool sample for fecal calprotectin (FC) was also collected to assess for subclinical inflammation. The primary outcome measure was QoL assessed by the short inflammatory bowel disease questionnaire (SIBDQ), with planned subgroup comparisons for fatigue, anxiety, depression and IBS symptoms. Results Ninety-three patients were eligible for inclusion in this study. The median SIBDQ scores were lower in patients with anxiety (P < 0.001), depression (P = 0.004), IBS symptoms (P < 0.001) and fatigue (P = 0.018). Elevated FC in patients in clinical remission did not impact QoL. These findings were consistent on multivariate linear regression. Conclusions Anxiety, depression, fatigue and IBS symptoms are all independently associated with lower QoL in patients with inactive IBD. Clinicians are encouraged to screen for these important factors as they may detrimentally impact QoL in IBD patients even in clinical remission.

Sign in / Sign up

Export Citation Format

Share Document